Vifor Pharma

Pharmaceuticals
VIFN.SW
CHF 178 (0.56)%
Share price
$ 12 bn
Market Cap
$ 11 bn
Enterprise Value

Carbon footprint

0.6 Ton
GHG emissions per $ 1 mln investment
0.02x the weighted average for S&P 500
FY2020
How is this calculated?
-23%
YOY change in GHG emissions
Stronger than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Vifor Pharma's GHG emissions (market-based) (Kt of CO2e)

Vifor Pharma's carbon footprint

Vifor Pharma reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 6.8 Kt (-2 /-23.1% y-o-y).

Vifor Pharma's Scope 3 emissions tumbled to 6.8 Kt (-3.9 /-36.4% y-o-y). The performance has been erratic recently.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...